The Food and Drug Administration on Tuesday approved Merck & Co.’s drug Keytruda for the treatment of blood cancer. The immunotherapy drug, first approved in 2014, can now be used to treat patients ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...
Hosted on MSN
Oncologists explain why they prescribe Keytruda to cancer patients, when and how it works
Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...
Overview: Keytruda Qlex is a medicine that is used to treat many types of cancer. This medicine is given to you as an injection under your skin by a health care provider. This medicine can cause side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results